GFH-276

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameGFH-276
Drug Alias NameGFH276GFH-276
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCyclophilin A modulatorsGTPase Ras inhibitors
TargetsCyclophilin AGTPase Ras
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGenfleet Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGenfleet Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A